«Immunogenetics

Below is an extended Immunogenetics patents listing. Click here to return to the Immunogenetics main in depth entry.

Patents :
US Patent No.	Title
7378234	Method for isolating hepatitis C virus peptides
7390619	Optimization of immunomodulatory properties of genetic vaccines
7390626	Methods and kit for diagnosing tick borne illnesses
7390633	Methods for preparing low molecular weight heparin with modified heparinase III
7390782	Methods and products related to metabolic interactions in disease
7390871	Tumor antigen based on products of the tumor suppressor gene WT1
7390872	NF-.kappa.B peptides designed to disrupt NEMO oligomerization
7390879	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7393529	Methods and compositions for inhibiting binding of IgE to a high affinity receptor
7393634	Screening for disease susceptibility by genotyping the CCR5 and CCR2 genes
7393942	Nucleic acids encoding mutant forms of Fas ligand
7388072	MAGE peptides presented by HLA class II molecules
7387993	Mannan-binding lectin (MBL) treatment of infections in individuals treated with TNF-.alpha.inhibitors
7378384	WT1 substitution peptides
7381413	Methods and products related to metabolic interactions in disease
7381544	Nucleic acid that encodes a fusion protein
7381794	Dimeric fusion proteins and materials and methods for producing them
7381798	Recombinant antibody recognizing dioxin and gene encoding the antibody
7385023	Cancer immunotherapy and diagnosis using cytochrome P450 1B1
7385036	Human tango 509 polypeptides
7385044	Isolated peptides which bind to MHC Class II molecules, and uses thereof
7385045	Canine B7-1 nucleic acid molecules
7387882	Predictive assay for immune response
7396681	Application of Hsp70 proteins
7399604	Methods and products related to evaluating the quality of a polysaccharide
7399613	Sialic acid nucleotide sugars
7410643	Materials and methods relating to fusion proteins for inducing an immune response
7410779	Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
7411042	Tumor associated nucleic acids and uses therefor
7414123	Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies
7416726	Enhancement of antibody-mediated immune responses
7416727	Polypeptide variants with altered effector function
7416851	Method of diagnosis/prognosis of human chronic lymphocytic leukemia comprising the profiling of LPL/ADAM genes
7416858	Pharmaceutical compositions of glycoconjugates
7417062	Substituted arylamides
7417121	Human G-protein coupled receptor, HGPRBMY39
7408041	Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
7408038	Secreted immunomodulatory proteins
7399743	Targeted thrombosis
7399827	Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
7399834	Anti-PRO1558 antibodies
7399838	Single chain class I major histo-compatibility complexes
7399849	Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
7402430	MHC class II antigen-presenting systems and methods for activating CD4.sup.+ T cells
7404270	Tumor antigen
7405198	Glycopegylated erythropoietin
7405290	Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
7408037	Tumor antigen
7417128	7C10 and 16C10 CD80-specific antibodies

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.